G. Peter Gliebus, M.D., is a board-certified neurologist and director of cognitive and behavioral neurology at Marcus Neuroscience Institute, a part of Baptist Health. He is fluent in English and Lithuanian.

Dr. Gliebus has a subspecialty certification in behavioral neurology and neuropsychiatry, and specializes in the diagnosis and treatment of conditions and diseases involving the central and peripheral nervous system. His clinical interests include Alzheimer’s disease and other neurodegenerative dementias as well as cognitive problems associated with stroke and similar conditions.

Prior to joining Marcus Neuroscience Institute, Dr. Gliebus served as academic chair of the Department of Neurology at Drexel University College of Medicine, chief of neurology and director of the Alzheimer’s Disease and Cognitive Disorder Center at Crozer Keystone Healthcare System, as well as chair of neurology at Global Neurosciences Institute.

Dr. Gliebus earned his medical degree at the Faculty of Medicine of Vilnius University in Lithuania. He completed a neurology residency at Drexel University College of Medicine, serving as chief resident. He also completed a behavioral neurology and neuropsychiatry fellowship at Northwestern University Feinberg School of Medicine.

For several consecutive years, Dr. Gliebus has been recognized as a Castle Connolly Top Doctor. Physicians receiving this peer-nominated honor are best-in-class healthcare providers, embodying excellence in clinical care as well as interpersonal skills.

Through his years of experience, Dr. Gliebus has developed a comprehensive understanding of the challenges that individuals and their families face when dealing with cognitive disorders. He provides compassionate, personalized care to patients, ensuring accurate diagnosis, effective treatment plans and ongoing support throughout their journey. By staying up to date with the latest advancements in the field, he offers the most comprehensive and innovative approaches to improve the quality of life for individuals with cognitive disorders.

Dr. Gliebus is committed to advancing medical knowledge and finding innovative solutions to complex healthcare challenges. He is the principal investigator for several clinical trials related to memory disorders and dementia. During his involvement in Alzheimer's disease treatment trials, he witnessed firsthand the positive impact that a newly approved medication group had on patients and families.

Dr. Gliebus is credited with more than 60 publications and presentations, is an editorial reviewer for various national specialty journals and editor of the book entitled Progressive Cognitive Impairment and Its Neuropathologic Correlates.

As an educator, Dr. Gliebus shares his wisdom with medical students. He finds that the opportunity to teach and mentor others deepens his knowledge and empowers future generations of healthcare professionals. Dr. Gliebus is a fellow of the American Academy of Neurology and member of the Society for Behavioral and Cognitive Neurology and the Alzheimer’s Association.

He likes to be active during his free time, engaging in physical activities such as running, hiking and other sports. He enjoys exploring new destinations, tasting exotic cuisines and learning about the history and culture of the places he visits. He is also an avid reader, favoring intriguing mysteries and history books.